Evrofarma (ATH:EVROF) Interest Expense : € Mil (TTM As of . 20)

View and export this data going back to 2000. Start your Free Trial

What is Evrofarma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Evrofarma's interest expense for the three months ended in . 20 was € 0.00 Mil. Evrofarma does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Evrofarma's Operating Income for the three months ended in . 20 was € 0.00 Mil. Evrofarma's Interest Expense for the three months ended in . 20 was € 0.00 Mil. Evrofarma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evrofarma Interest Expense Historical Data

The historical data trend for Evrofarma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evrofarma Interest Expense Chart

Evrofarma Annual Data

Trend

Interest Expense

Evrofarma Quarterly Data

Interest Expense

Evrofarma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Evrofarma (ATH:EVROF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Evrofarma's Interest Expense for the three months ended in . 20 was €0.00 Mil. Its Operating Income for the three months ended in . 20 was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was €0.00 Mil.

Evrofarma's Interest Coverage for the quarter that ended in . 20 is calculated as

Evrofarma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Evrofarma (ATH:EVROF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Evrofarma SA (ATH:EVROF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 km Didimoticho-Orestiada, Didimoticho, GRC, 68300

Website

http://www.evrofarma.gr

Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.

Evrofarma (ATH:EVROF) Headlines

No Headlines